The U.S. Attorney's Office has joined the investigation of Swedish-Cherry Hill's neurosciences institute in Seattle, The Seattle Times reports.
Here's what you should know.
1. Swedish Interim CEO Guy Hudson, MD, MBA, wrote a memo to the staff, noting the institute will "cooperate fully to ensure that we are living our values and upholding the highest standards."
2. The Seattle Times reports a Swedish spokesperson currently has no information about whether the federal investigation is criminal or civil.
3. The Department of Health has already launched an investigation into two complaints filed against former Swedish Neuroscience Institute Chair Johnny B. Delashaw, MD, in the past 12 months. Dr. Delashaw resigned from his post on March 1, 2017.
4. On Feb. 10, 2017, The Seattle Times published an investigative report into Providence Health & Services Swedish-Cherry Hill hospital's spine and neurosurgery services. The report revealed the health system decided to overhaul Cherry Hill's neuroscience program to treat more high-risk patients. The invasive brain and spine procedures generated around $500 million in net operating revenue in 2015 as well as saw higher Medicare reimbursement per inpatient visit than any other hospital of its size.
5. Shortly after on Feb. 20, 2017, Anthony Armada left his post as CEO of Seattle-based Swedish Health Services..